Young Suk Park

11.0k citations
232 papers · 6.5k · 2 hit papers · h-index 42

Impact in

  • Oncology top 0.5%
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Surgical Treatments
    • Cancer Genomics and Diagnostics

Papers in

    • Colorectal Cancer Treatments and Studies 52
    • Pancreatic and Hepatic Oncology Research 23
    • Colorectal Cancer Surgical Treatments 17
    • Lung Cancer Research Studies 12
    • Gastric Cancer Management and Outcomes 29

Young Suk Park

223 papers receiving 6.4k citations

Young Suk Park's Hit Papers

Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses 2015 · 305 citations
3050+4+9Years since publication100200300400

Peers

Young Suk Park
Comparison fields: 5 of 113
  • Oncology 3.2k
  • Cancer Research 904
  • Pulmonary and Respiratory Medicine 1.6k
  • Gastroenterology 276
  • Hepatology 332
Replace Mark M. Zalupski with:
Mark M. Zalupski United States
Kun‐Huei Yeh Taiwan
Naureen Starling United Kingdom
Thierry Lecomte France
Ferdinando De Vita Italy
Rachna T. Shroff United States
Gennaro Galizia Italy
Vladimir Moiseyenko Russia
Masayuki Ohue Japan
Robert R. McWilliams United States
Young Suk Park relative to Mark M. Zalupski United States Mark M. Zalupski's profile →
Citations per field
00.5×1.6×
Mark M. Zalupski · 1×
Citations per year

Countries citing papers authored by Young Suk Park

Since Specialization
Citations

This map shows the geographic impact of Young Suk Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young Suk Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young Suk Park more than expected).

Fields of papers citing papers by Young Suk Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young Suk Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young Suk Park. The network helps show where Young Suk Park may publish in the future.

Co-authors

The 25 scholars most cited alongside Young Suk Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Young Suk Park Line = papers co-authored together Young Suk Park links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 232 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone
Hit paper breakdown →
2012486
2 2011333
3
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses
Hit paper breakdown →
2015305
4 2014271
5 2017183
6 2015151
7 2005142
8 2011124
9 2016107
10 2007106
11 2011104
12 2013103
13 2018103
14 200699
15 201293
16 201493
17 200486
18 201176
19 201273
20 202071

About Young Suk Park

Young Suk Park is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Cancer Research, having authored 232 papers that have together received 6.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (52 papers), Gastric Cancer Management and Outcomes (29 papers), Pancreatic and Hepatic Oncology Research (23 papers), Neuroendocrine Tumor Research Advances (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers), Colorectal Cancer Surgical Treatments (17 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Lung Cancer Research Studies (12 papers). The work is most often cited by research in Oncology (3.2k citations), Cancer Research (904 citations), Pulmonary and Respiratory Medicine (1.6k citations), Gastroenterology (276 citations) and Hepatology (332 citations). Young Suk Park has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Joon Oh Park, Won Ki Kang, Jeeyun Lee, Ho Yeong Lim, Se Hoon Park, Seung Tae Kim, Kyoung‐Mee Kim, Keon Woo Park, Keunchil Park and Hee Cheol Kim. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Treatment, Cancer Chemotherapy and Pharmacology, Journal of Cancer and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact